Abbott is a leading medical device company based in Los Angeles, CA, specializing in the development of implantable cardiac defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) to manage heart rhythm irregularities. Their innovative devices, such as the Abbott Entrant, Gallant, and Neutrino NxT, are designed to provide reliable treatment and peace of mind through secure, remote monitoring using the myMerlinPulse app.
With a commitment to helping individuals live life on their own terms, Abbott aims to empower patients by offering resources to understand how their devices manage their condition. Their ICD and CRT-D devices are indicated for the automated treatment of life-threatening ventricular arrhythmias, while the myMerlinPulse app allows patients to discreetly collect and share important information about their heart with their healthcare provider. Abbott's focus on secure and safe therapy ensures that individuals can feel better, live better, and have the freedom to pursue what matters most to them.
Generated from the website